ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 141174" data-attributes="member: 13851"><p><a href="https://clinicaltrials.gov/ct2/show/NCT03864913" target="_blank">Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents - Full Text View - ClinicalTrials.gov</a></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Study Description</span></strong></p><p></p><p></p><p><strong><span style="color: rgb(0, 0, 0)">Brief Summary:</span></strong></p><p>The trial studies the efficacy of subcutaneous (SQ) testosterone compared to intramuscular (IM) testosterone therapy during the first 6 months of pubertal induction in transgender male adolescents. Describes rate of adverse effects, masculinizing effects and quality of life while receiving testosterone. Evaluates clinic utilization required for testosterone therapy.</p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Detailed Description:</span></strong></p><p></p><p><span style="color: rgb(0, 0, 0)"><strong>Objectives:</strong></span></p><ol> <li data-xf-list-type="ol">Determine the efficacy of SQ testosterone compared to IM testosterone therapy. Hypothesis: SQ testosterone is equally efficacious to IM testosterone in achieving mid-pubertal testosterone levels and masculinizing physical changes in transgender male adolescents after 6 months.</li> <li data-xf-list-type="ol">Determine the rate of adverse reactions of SQ and IM testosterone during the first 6 months of treatment.<br /> <strong><span style="color: rgb(184, 49, 47)">Hypothesis:</span></strong> SQ testosterone results in equal or fewer adverse reactions than IM testosterone.</li> <li data-xf-list-type="ol">Evaluate quality of life (QOL) and satisfaction of injection technique for SQ and IM testosterone.<br /> <strong><span style="color: rgb(184, 49, 47)">Hypothesis:</span></strong> Subjects receiving SQ testosterone will report equal or superior quality of life and satisfaction with injection technique compared to IM testosterone as SQ is less painful and easier to administer at home.</li> <li data-xf-list-type="ol">Evaluate and compare the number of clinical visits required for testosterone injections by transgender male patients receiving SQ and IM therapy.<strong><span style="color: rgb(184, 49, 47)"><br /> Hypothesis:</span></strong> Subjects using SQ testosterone will have fewer clinic visits than those using IM testosterone. This may impact healthcare-related costs.</li> </ol><p></p><p></p><p><strong><span style="color: rgb(0, 0, 0)">Study Outline:</span></strong></p><p>6 month study consisting of three study visits at baseline, 3 months and 6 months. Optional cross over of injection modality from 6-9 months. At each visit subjects complete blood work and questionnaires to determine testosterone peak and trough levels as well as biochemical adverse effects, quality of life, masculinizing effects and medication experience.</p></blockquote><p></p>
[QUOTE="madman, post: 141174, member: 13851"] [URL='https://clinicaltrials.gov/ct2/show/NCT03864913']Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents - Full Text View - ClinicalTrials.gov[/URL] [B][COLOR=rgb(184, 49, 47)]Study Description[/COLOR][/B] [B][COLOR=rgb(0, 0, 0)]Brief Summary:[/COLOR][/B] The trial studies the efficacy of subcutaneous (SQ) testosterone compared to intramuscular (IM) testosterone therapy during the first 6 months of pubertal induction in transgender male adolescents. Describes rate of adverse effects, masculinizing effects and quality of life while receiving testosterone. Evaluates clinic utilization required for testosterone therapy. [B][COLOR=rgb(184, 49, 47)]Detailed Description:[/COLOR][/B] [COLOR=rgb(0, 0, 0)][B]Objectives:[/B][/COLOR] [LIST=1] [*]Determine the efficacy of SQ testosterone compared to IM testosterone therapy. Hypothesis: SQ testosterone is equally efficacious to IM testosterone in achieving mid-pubertal testosterone levels and masculinizing physical changes in transgender male adolescents after 6 months. [*]Determine the rate of adverse reactions of SQ and IM testosterone during the first 6 months of treatment. [B][COLOR=rgb(184, 49, 47)]Hypothesis:[/COLOR][/B] SQ testosterone results in equal or fewer adverse reactions than IM testosterone. [*]Evaluate quality of life (QOL) and satisfaction of injection technique for SQ and IM testosterone. [B][COLOR=rgb(184, 49, 47)]Hypothesis:[/COLOR][/B] Subjects receiving SQ testosterone will report equal or superior quality of life and satisfaction with injection technique compared to IM testosterone as SQ is less painful and easier to administer at home. [*]Evaluate and compare the number of clinical visits required for testosterone injections by transgender male patients receiving SQ and IM therapy.[B][COLOR=rgb(184, 49, 47)] Hypothesis:[/COLOR][/B] Subjects using SQ testosterone will have fewer clinic visits than those using IM testosterone. This may impact healthcare-related costs. [/LIST] [B][COLOR=rgb(0, 0, 0)]Study Outline:[/COLOR][/B] 6 month study consisting of three study visits at baseline, 3 months and 6 months. Optional cross over of injection modality from 6-9 months. At each visit subjects complete blood work and questionnaires to determine testosterone peak and trough levels as well as biochemical adverse effects, quality of life, masculinizing effects and medication experience. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top